Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
09/2006
09/19/2006US7108986 A diagnostic agent comprising a reporting molecule attached to the binding molecule for detecting human cancers
09/19/2006US7108985 Detecting preferential peptide in sample; obtain sample, incubate with label, release peptide, analyzing the released peptides by mass spectrometry
09/19/2006US7108984 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of tumors
09/19/2006US7108983 Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker
09/19/2006US7108982 Providing a blood sample from a subject to be tested for age-related macular degeneration; determining whether the sample has protein markers for abdominal aortic aneurysm (AAA)
09/19/2006US7108981 Administering monoclonal antibody that specifically binds Kaposi's sarcoma-associated herpesvirus (KSHV) interleukin-6 (vIL-6), wherein the monoclonal antibody is produced by a hybridoma in a pharmaceutically acceptable carrier for therapy of Kaposi's sarcoma-associated herpesvirus infection
09/19/2006US7108977 Process for determining the tumoricidal potential of a sample the use of a nucleic acid which is downregulated in human tumor cells
09/19/2006US7108975 Atlastin
09/19/2006US7108971 For use in hybridization/purification/immunoassays/biosensors; solid phase synthesis
09/19/2006US7108970 Rapid identification of conditions, compounds, or compositions that inhibit, prevent, induce, modify, or reverse transitions of physical state
09/19/2006US7108967 Using immunoglobulin which binds specifically to hepatitis envelope antigens E1 and E2 to detect viral infection
09/19/2006US7108915 Conjugated with an antibody, antigen, enzyme, binding protein, oligonucleotide, polypeptide, or receptor agonist or antagonist; analytical and combinatorial chemistry, medical diagnostics, and genetic analysis
09/19/2006US7108856 Comprise viral amino acid sequences for use in vaccine preparation and prevention of viral infection
09/19/2006US7108854 Also an antibody which specifically binds to the protein and a Hybridoma cell line that produces the protein; immunoprophylactic uses
09/19/2006US7108853 Surface protein of Leptospira
09/19/2006US7108846 Methods for preparing perfluorinated [18f]-radiolabelled nitroimidazole derivatives for cellular hypoxia detection
09/19/2006US7108778 Electrochemical sensors including electrode systems with increased oxygen generation
09/19/2006US7108774 Method for analyzing a papermaking process and an electrochemical sensor for analyzing liquid
09/19/2006US7107858 Hot mix asphalt load simulator
09/19/2006US7107852 Method of inspecting food stuffs and/or associated packaging
09/19/2006CA2298181C Non-targeted complex sample analysis
09/19/2006CA2269442C Storage container for analytical devices
09/19/2006CA2252024C Method and apparatus for the measurement of components of exhaled breath in humans
09/19/2006CA2235269C Monoclonal antibody br110 and uses thereof
09/19/2006CA2140989C Phenyl-substituted alkylcarboguanidides carrying perfluoroalkyl groups, a process for their preparation, their use as a medicament or diagnosticagent, and a medicament containing them
09/19/2006CA2083493C Association between a human immunodeficiency virus-related retrovirus and sjogren's syndrome
09/18/2006CA2758158A1 Tape magazine for a hand-held device for analysing a body fluid, and a hand-held device
09/18/2006CA2501274A1 A competitive binding assay for cell surface charge
09/15/2006CA2539781A1 Methods for substrate and inhibitor screening using enzyme-reactor, chromatography/tandem mass spectrometry
09/15/2006CA2538849A1 Method and system for investigating glucose metabolism
09/15/2006CA2500932A1 Methods for substrate and modulator screening using enzyme-reactor, chromatography/tandem mass spectrometry
09/14/2006WO2006096861A2 METHODS FOR IDENTIFYING TUMORS RESPONSIVE TO TREATMENT WITH HER DIMERIZATION INHIBITORS (HDIs)
09/14/2006WO2006096780A2 Sirtuin related therapeutics and diagnostics for neurodegenerative diseases
09/14/2006WO2006096746A1 Entrapped binding protein as biosensors
09/14/2006WO2006096735A2 Enhancing a luminescent signal
09/14/2006WO2006096710A2 Detection, imaging, and depletion of chlamydia
09/14/2006WO2006096703A2 Method for assessing pyrimidine metabolism
09/14/2006WO2006096697A2 Methods for determining the bivalency of protein and antibody therapeutics
09/14/2006WO2006096691A1 Determination of folate in samples of serum or plasma
09/14/2006WO2006096619A2 Stabilizing the activity of pqq-dependent glucose dehydrogenase in electrochemical biosensors
09/14/2006WO2006096468A2 Enhanced detection of biological and bioactive components by resonance raman spectroscopy
09/14/2006WO2006096451A2 Methionine sulfoxide antibodies
09/14/2006WO2006096255A2 Thermoplastic film having metallic nanoparticle coating
09/14/2006WO2006096126A1 A method, device and system for volumetric enumeration of white blood cells.
09/14/2006WO2006096071A1 Estimating strengths of wooden supports
09/14/2006WO2006095905A1 Tumor marker and diagnostic kit using the same
09/14/2006WO2006095897A1 Screening method
09/14/2006WO2006095833A1 Method for examining thrombosis-related disease by assaying microthrombus
09/14/2006WO2006095758A1 Method of avoiding substrate inhibition by pqqgdh
09/14/2006WO2006095757A1 Multilayer analytical element
09/14/2006WO2006095744A1 Method of fluorescent-labeling saccharides and appratus for fluorescent-labeling saccharides
09/14/2006WO2006095731A1 CRYSTAL OF COMPLEX OF Rho-KINASE AND SUBSTANCE CAPABLE OF INTERACTING WITH Rho-KINASE
09/14/2006WO2006095654A1 Reporter gene assay method
09/14/2006WO2006095559A1 USE OF Fgf21 AS HEMATOPOIETIC FACTOR
09/14/2006WO2006095267A1 Compositions for the treatment of tumour pathologies, comprising internalin b (in1b) of listeria monocytogene protein or a fragment thereof
09/14/2006WO2006095259A2 Biomarkers for cardiovascular side-effects induced by cox-2 inhibitory compounds
09/14/2006WO2006095181A2 Biosensor labelling groups
09/14/2006WO2006095167A1 Appetite-influencing medicaments
09/14/2006WO2006095158A1 Prediction of metastasis
09/14/2006WO2006095077A2 In vitro determination of the reactivity of an entity on a three-dimensional functional element
09/14/2006WO2006095041A1 Method for the in vitro diagnosis of alzheimer's disease using a monoclonal antibody
09/14/2006WO2006095011A1 Engineered human cells
09/14/2006WO2006094805A1 Photoproteins with enhanced bioluminescence and their use as intracellular calcium indicators
09/14/2006WO2006094748A2 Method for evaluating the vitality of chlorophyll-containing biological samples
09/14/2006WO2006094747A1 Determination of short-chain srl-alcohol dehydrogenase (dhrs4) as biomarker of inflammations and infections
09/14/2006WO2006094745A1 Photo activatable amino acids
09/14/2006WO2006094735A1 Use of mgc4504
09/14/2006WO2006094724A2 Screening method, process for purifying of non-diffusible a-beta oligomers, selective antibodies against said non-diffusible a-beta oligomers and a process for manufacturing of said antibodies
09/14/2006WO2006094716A1 Method for ckecking and controlling the mammalian lactic acid fermentation process/aerobic glucose fermentation metabolic pathway in mammalian organism
09/14/2006WO2006094704A2 Natural ligand of g protein coupled receptor rcc356 and uses thereof
09/14/2006WO2006094703A1 Use of an antagonist of epac for treating human cardiac hypertrophy
09/14/2006WO2006094688A1 Organic compounds
09/14/2006WO2006094467A1 A blood purification method and system based on affinity absorption
09/14/2006WO2006094402A1 Novel hemoglobin scavenger receptor, cd163, and method of increasing cd163 expression on human stem cells and stimulation of erythroid progenitors
09/14/2006WO2006094389A1 Assay device for detection and testing of diseases on spaced apart membranes
09/14/2006WO2006094375A1 Correction for temperature dependence of assays
09/14/2006WO2006094356A1 Disc substrates for combinatorial chemistry
09/14/2006WO2006085958A3 Integration of direct binding sensors with mass spectrometry for functional and structural characterization of molecules
09/14/2006WO2006081353A3 Rapid comparative genome hybridization
09/14/2006WO2006080017A3 Biologically active silver-coated proteins
09/14/2006WO2006078470A3 Cell separation using microchannel having patterned posts
09/14/2006WO2006075172A3 Methods for identifying compounds capable of modulating cftr/ck2 interaction and/or cftr phosphorylation by ck2
09/14/2006WO2006075142A3 FORMS OF FACTOR XIIa
09/14/2006WO2006074947A3 METHODS AND ASSAYS FOR DISTINGUISHING BETWEEN DIFFERENT FORMS OF DISEASES AND DISORDERS CHARACTERIZED BY THROMBOCYTOPENIA AND/OR BY SPONTANEOUS INTERACTION BETWEEN VON WILLEBRAND FACTOR (vWF) AND PLATELETS
09/14/2006WO2006071805A9 Perinucleolar compartment markers for cancers
09/14/2006WO2006069373A8 Diagnosis of preeclampsia
09/14/2006WO2006069073A3 Use of angiopoietins in anti-tumor therapy
09/14/2006WO2006067427A3 Method of diagnosis
09/14/2006WO2006065802A3 Automated immunoassay cassette, apparatus and method
09/14/2006WO2006061242A3 Use of pta peptides for stratification of individuals having cancer
09/14/2006WO2006056579A3 Tailored magnetic particles and method to produce same
09/14/2006WO2006052924A3 Methods and compositions for protein-hydroxy apatite complexes and their application in testing and modulating immunological system including a novel in vitro test for the detection of antibodies against calcium binding protein-hydroxy apatite complexes
09/14/2006WO2006039258A3 Human antibodies against parathyroid hormone
09/14/2006WO2006031883A3 Analysis of mhc-peptide binding interactions
09/14/2006WO2006020684A3 Methods of regulating differentiation and treating of multiple myeloma
09/14/2006WO2006010533B1 Pancreatic polypeptide as target/marker of beta cell failure
09/14/2006WO2006008143A3 Apparatus components and methods of using apparatus components to detect the presence of an analyte
09/14/2006WO2005123940A3 Method and apparatus for detecting phycocyanin-pigmented algae and bacteria from reflected light
09/14/2006WO2005122712A3 Soluble low-density lipoprotein receptor related protein binds directly to alzheimer’s amyloid-beta peptide
09/14/2006WO2005121793A3 Detection of methamphetamine group drugs